Drug Type Small molecule drug |
Synonyms Yaku A |
Target |
Action modulators, inhibitors |
Mechanism MC1R modulators(Melanocortin receptor 1 modulators), MITF inhibitors(melanocyte inducing transcription factor inhibitors), SIK1 inhibitors(salt inducible kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H24O3 |
InChIKeyTXELARZTKDBEKS-UHFFFAOYSA-N |
CAS Registry78954-23-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Skin Pigmentation | Preclinical | South Korea | 06 Jun 2024 |